Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts

Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts

Molecular Cancer Therapeutics

Saved in:

Bibliographic Details
Main Authors:	Bani, M.R., Nicoletti, M.I., Alkharouf, N.W., Ghilardi, C., Petersen, D., Erba, E., Sausville, E.A., Liu, E.T., Giavazzi, R.
Other Authors:	MEDICINE
Format:	Review
Published:	2016
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/133027
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin
by: Daranee Sirichaisutdhikorn, et al.
Published: (2018)

Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin
by: Daranee Sirichaisutdhikorn, et al.
Published: (2018)

Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin.
by: Sirichaisutdhikorn D., et al.
Published: (2014)

Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin
by: Sirichaisutdhikorn D., et al.
Published: (2014)

Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells
by: Van Haaften, C, et al.
Published: (2020)

Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma
by: Wong, A.S.C., et al.
Published: (2011)

Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma
by: Wong, A.S.C., et al.
Published: (2011)

Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer
by: Kietpeerakool C., et al.
Published: (2014)

A case of ovarian paragonimiasis mimicking ovarian carcinoma
by: Charuwan Tantipalakorn, et al.
Published: (2018)

A case of ovarian paragonimiasis mimicking ovarian carcinoma
by: Charuwan Tantipalakorn, et al.
Published: (2018)

The Comparison of Neutropenia and Peripheral Neuropathy Condition as an Impact of 3-hours and 24-hour Paclitaxel Infusion of Paclitaxel-Carboplatin Chemotherapy on Ovarian Cancer Patients
by: Primandono Perbowo, -, et al.
Published: (2019)

Effective inhibition of xenografts of hepatocellular carcinoma (hepg2) by rapamycin and bevacizumab in an intrahepatic model
by: Ong, L.-C., et al.
Published: (2014)

Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft
by: Shaikh, I.M., et al.
Published: (2014)

Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer
by: Chumnan Kietpeerakool, et al.
Published: (2018)

Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft
by: Chaudhury, A., et al.
Published: (2014)

LIPID NANOSYSTEM FOR PACLITAXEL AND ALPHA MANGOSTIN: ADDRESSING DRUG RESISTANCE AND NEPHROTOXICITY ASSOCIATED WITH OVARIAN CANCER CHEMOTHERAPY
by: SANTWANA K C
Published: (2022)

Clinical pharmacokinetics of low dose paclitaxel in Asian patients with nasopharyngeal carcinoma
by: NIU HUI LIAN
Published: (2010)

Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models
by: Syn N.L., et al.
Published: (2019)

Identification of Functional Targets in Epithelial Ovarian Carcinoma
by: MIOW QING HAO
Published: (2014)

Correlation Between Superoxide Dismutase Serum Level Alteration with Neck Metastatic Tumor Post Cisplatin–Paclitaxel Chemotherapy Response in Nasopharyngeal Carcinoma Patients
by: Achmad Chusnu Romdhoni, NIDN. 0002097604, et al.
Published: (2018)

Correlation Between Superoxide Dismutase Serum Level Alteration with Neck Metastatic Tumor Post Cisplatin–PaclitaxelChemotherapy Response in Nasopharyngeal Carcinoma Patients
by: Achmad Chusnu Rhomdhoni, Achmad, et al.
Published: (2019)

Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer
by: Basu, B, et al.
Published: (2021)

Preclinical evaluation of transcriptional targeting strategy for human hepatocellular carcinoma in an orthotopic xenograft mouse model
by: Sia, K.C., et al.
Published: (2014)

Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
by: Lee, Matilda X, et al.
Published: (2021)

Ovarian endometriosis associated with carcinoma and sarcoma: Case report
by: M. C. Boruban, et al.
Published: (2018)

Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel
by: Lee, J.H, et al.
Published: (2020)

Datasets describing the growth and molecular features of hepatocellular carcinoma patient-derived xenograft cells grown in a three-dimensional macroporous hydrogel
by: Fong, E.L.S., et al.
Published: (2021)

Kuguacin J isolated from bitter melon leaves modulates paclitaxel sensitivity in drug-resistant human ovarian cancer cells
by: Pornsiri Pitchakarn, et al.
Published: (2018)

Kuguacin J isolated from bitter melon leaves modulates paclitaxel sensitivity in drug-resistant human ovarian cancer cells
by: Pornsiri Pitchakarn, et al.
Published: (2018)

Kuguacin J isolated from bitter melon leaves modulates paclitaxel sensitivity in drug-resistant human ovarian cancer cells
by: Pitchakarn P., et al.
Published: (2017)

Kuguacin J isolated from bitter melon leaves modulates paclitaxel sensitivity in drug-resistant human ovarian cancer cells
by: Pornsiri Pitchakarn, et al.
Published: (2018)

Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma
by: Yuen, J.S.P, et al.
Published: (2020)

CYSTEINE DEPRIVATION AS A POTENTIAL THERAPEUTIC MODALITY FOR OVARIAN CARCINOMA
by: WISNA NOVERA
Published: (2018)

Huge peritoneal malignant mesothelioma mimicking primary ovarian carcinoma
by: Siriwan Tangjitgamol, et al.
Published: (2018)

Obscure Bleeding from an Ovarian Carcinoma Invading the Small Bowel
by: Heidi C.S.Y., et al.
Published: (2018)

Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma
by: Yabuno, A., et al.
Published: (2021)

Erosive osteoarthritis during treatment with bevacizumab and paclitaxel in a patient with recurrent papillary serous carcinoma of the ovary
by: A. Jaishuen, et al.
Published: (2018)

Immunological tolerance in allo- and xenografts
by: Aftab A. Ansari, et al.
Published: (2018)

Colposcopic diagnosis of ovarian carcinoma spreading to cervix: A case report
by: Singh, P., et al.
Published: (2013)

A Series of Ovarian Clear Cell and Endometrioid Carcinoma and their Association with Endometriosis
by: Chew, S., et al.
Published: (2013)